AIDS

1. CORDOVA E, Rendon JH, Calderon GA, Seleme S, et al
   Efficacy of dolutegravir plus lamivudine in treatment-naive people with HIV with baseline transmitted drug-resistance mutations.
   AIDS. 2026 Jan 15. doi: 10.1097/QAD.0000000000004444.
   

   >> Share

   
   

   
   Am J Med

2. MURRAY HW
   Infectious Diseases and Blood Supply Safety in the United States in 2026: A Review.
   Am J Med. 2026 Jan 13:S0002-9343(26)00049-5. doi: 10.1016/j.amjmed.2026.
   

   >> Share

   
   

   
   Clin Infect Dis

3. FONCILLAS A, Ambrosioni J, Sempere A, Berrocal L, et al
   Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles.
   Clin Infect Dis. 2026 Jan 14:ciag023. doi: 10.1093.
   

   >> Share

   
   
4. NALUGWA T, Shah KM, Marcelo D, Nakawunde R, et al
   Predicted Preferences for Tuberculosis Point-of-Care Tests among Tuberculosis-Affected Individuals in Five High Burden Countries.
   Clin Infect Dis. 2026 Jan 14:ciag022. doi: 10.1093.
   

   >> Share

   
   
5. DHAND A, Pouch SM
   Infections After Kidney Transplantation from Donors with HIV to Recipients with HIV: Insights, Prevention, and the Path Forward.
   Clin Infect Dis. 2026 Jan 12:ciaf657. doi: 10.1093.
   

   >> Share

   
   
6. ARANT EC, Davy-Mendez T, Liang T, Rodrigues M, et al
   Infections After Kidney Transplantation From Donors With Human Immunodeficiency Virus (HIV) to Recipients With HIV.
   Clin Infect Dis. 2026 Jan 12:ciaf656. doi: 10.1093.
   

   >> Share

   
   

   
   Int J Dermatol

7. COSTA SPD, Sardinha JC, Costa ASD, Heibel M, et al
   Unusual Presentation of Kaposi Sarcoma in a Virally Suppressed HIV Patient With High CD4 Counts.
   Int J Dermatol. 2026 Jan 14. doi: 10.1111/ijd.70264.
   

   >> Share

   
   
8. GAMBICHLER T, Schweer J, Weyer-Fahlbusch SS, Ducker P, et al
   Extensive Anogenital Molluscum Contagiosum Revealing Idiopathic CD4 Lymphocytopenia With CD8 T-Cell Depletion.
   Int J Dermatol. 2026 Jan 13. doi: 10.1111/ijd.70262.
   

   >> Share

   
   

   
   J Acquir Immune Defic Syndr

9. NDLOVU N, Plagianos M, Palanee-Phillips T, Reddy K, et al
   Adherence, Preference, and Acceptability of an Overencapsulated Dual Prevention Pill for HIV and Pregnancy Prevention Among Women in Johannesburg, South Africa.
   J Acquir Immune Defic Syndr. 2026;101:141-152.
   

   >> Share

   
   

   
   J Infect Dis

10. KENNEDY J, Cooley SA, Roman Fox J, Petersen KJ, et al
    Longitudinal changes in cognition and brain imaging in persons with HIV.
    J Infect Dis. 2026 Jan 16:jiag029. doi: 10.1093.
    

    >> Share

    
    
11. WILT AL, Meya DB, Cresswell FV, Wele A, et al
    CSF Hypo-Inflammation Drives Mortality in HIV-Associated Tuberculous Meningitis.
    J Infect Dis. 2026 Jan 12:jiag032. doi: 10.1093.
    

    >> Share

    
    
12. PETERSON TE, Hahn VS, Moaddel R, Zhu M, et al
    HIV-Associated Proteomic Signature of Myocardial Fibrosis and Incident Heart Failure.
    J Infect Dis. 2026 Jan 12:jiag013. doi: 10.1093.
    

    >> Share

    
    

    
    J Med Virol

13. WANG F, Song X, Zheng L, Zhang L, et al
    Chinese HIV Controllers Exhibit Different Immunophenotypic Profiles and Viral Reservoir Dynamics Compared to Normal Progressors: A Real-World Cohort Study.
    J Med Virol. 2026;98:e70756.
    

    >> Share

    
    

    
    Lancet Infect Dis

14. WOHL DA, Pewu C, Lee C, Kerkula E, et al
    Lassa fever symptomatology, viral dynamics, and host immune response (PREPARE): a prospective, observational cohort study in Liberia.
    Lancet Infect Dis. 2026 Jan 7:S1473-3099(25)00725.
    

    >> Share

    
    
15. LEITNER DR, Walsh SR, Suzuki M, Desjardins M, et al
    Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomised, placebo-controlled trial.
    Lancet Infect Dis. 2026 Jan 7:S1473-3099(25)00682.
    

    >> Share

    
    

    
    Nat Med

16. DONOVAN J, Duc Bang N, Dong HKT, Ho DTN, et al
    Genotype-stratified adjunctive dexamethasone for tuberculous meningitis in HIV-negative adults: a randomized controlled phase 3 trial.
    Nat Med. 2026 Jan 15. doi: 10.1038/s41591-025-04138.
    

    >> Share

    
    

    
    PLoS One

17. LIEGEON G, Mason JA, Friedman EE, Toribio M, et al
    A cross-sectional survey to explore healthcare providers' experiences and attitudes toward HIV pre-exposure prophylaxis for women in family planning centers of Greater Paris.
    PLoS One. 2026;21:e0337510.
    

    >> Share

    
    
18. WISCOVITCH-RUSSO R, Sui H, Smith M, Imamichi H, et al
    An immunofluorescence microscopy assay to discriminate distinct expression patterns of HIV-1 Gag and Nef proteins in HIV-1 provirus-harboring cells.
    PLoS One. 2026;21:e0340463.
    

    >> Share

    
    
19. KIM D, Gile KJ, Mathers B, Mirandola M, et al
    Comparing snowball sampling and RDS: A methodology and case study.
    PLoS One. 2026;21:e0331666.
    

    >> Share

    
    
20. KOYALTA D, Nodjikouambaye ZA, Muwonga Tukisadila J, Abdoulaye Bargo HD, et al
    Anal HPV shedding assessed by self-sampling and multiplex real-time PCR among men who have sex with men in N'Djamena, Chad: a feasibility and acceptability study.
    PLoS One. 2026;21:e0340799.
    

    >> Share

    
    
21. SHISHAY AS, Gebrezgiabher BB, Gebreyohannes YK, Negash BM, et al
    Time to treatment failure and its predictors among children receiving first-line antiretroviral therapy in Tigray Region public general hospitals, North Ethiopia, 2024: Retrospective cohort study.
    PLoS One. 2026;21:e0339269.
    

    >> Share

    
    

    
    PLoS Pathog

22. MUIR L, Suchanek O, Thomas P, Griffith SA, et al
    Multifaceted B cell response to transient HIV viremia in elite controllers.
    PLoS Pathog. 2026;22:e1013817.
    

    >> Share

    
    
23. SVANBERG C, Prasad Mukku R, Besler SO, Hopkins FR, et al
    HIV-1 derived oligonucleotides induce a type I IFN/STING dependent immune suppression reversible by targeting IFNARI.
    PLoS Pathog. 2026;22:e1013868.
    

    >> Share

    
    
24. SADRI G, Nadakal ST, Lauer W, Kos J, et al
    Development and validation of HIV SMRTcap for the characterization of HIV-1 reservoirs across tissues and subtypes.
    PLoS Pathog. 2026;22:e1013171.
    

    >> Share

    
    

    
    Virology

25. LAVIN TK, Tabler CO, Sweet TJ, Alhusaini N, et al
    Selective reactivation of latent HIV using CyclinT1-Tat-containing virus-like particles.
    Virology. 2026;616:110788.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share